Loading patent…
AssigneeNanjing Nutrabuilding Bio-Tech Co., Ltd.
InventorsMingru WANG, Ronghua YI, Shawn WELLS, Kylin LIAO
Estimating the term…
The present invention provides methods and compounds for enhancing mitochondrial biogenesis in a mammal or for activating PGC-1α in a mammal, comprising administrating to the mammal in need thereof a therapeutically effective amount of L-Ergothioneine, an analog or derivative thereof, or a pharmaceutically acceptable salt, acid, ester, analog or derivative thereof (e.g., as an active ingredient). Such administration of L-Ergothioneine is also capable of alleviating mitochondrial dysfunction and boosting cellular function by enhancing mitochondrial biogenesis, and/or promoting health and longevity by improving mitochondrial biogenesis.
A method for enhancing mitochondrial biogenesis in a mammal, comprising administrating to the mammal in need thereof a therapeutically effective amount of L-Ergothioneine, an analog or derivative thereof, or a pharmaceutically acceptable salt, acid, ester, analog or derivative thereof, as an active ingredient.
A composition for enhancing mitochondrial biogenesis in a mammal, comprising a therapeutically effective amount of L-Ergothioneine, an analog or derivative thereof, or a pharmaceutically acceptable salt, acid, ester, analog or derivative thereof, wherein the L-Ergothioneine effectively enhances mitochondrial biogenesis.
Use of L-Ergothioneine in manufacturing a composition for enhancing mitochondrial biogenesis in a mammal.
Dependencies are inferred from the claim text.